Cargando…
Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain
Somatostatin released from the capsaicin-sensitive sensory nerves mediates analgesic and anti-inflammatory effects via the somatostatin sst(4) receptor without endocrine actions. Therefore, sst(4) is considered to be a novel target for drug development in pain including chronic neuropathy, which is...
Autores principales: | Kántás, Boglárka, Börzsei, Rita, Szőke, Éva, Bánhegyi, Péter, Horváth, Ádám, Hunyady, Ágnes, Borbély, Éva, Hetényi, Csaba, Pintér, Erika, Helyes, Zsuzsanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940912/ https://www.ncbi.nlm.nih.gov/pubmed/31835716 http://dx.doi.org/10.3390/ijms20246245 |
Ejemplares similares
-
In Silico, In Vitro and In Vivo Pharmacodynamic Characterization of Novel Analgesic Drug Candidate Somatostatin SST(4) Receptor Agonists
por: Kántás, Boglárka, et al.
Publicado: (2021) -
Exploration of Somatostatin Binding Mechanism to Somatostatin Receptor Subtype 4
por: Börzsei, Rita, et al.
Publicado: (2022) -
Antinociceptive Effects of Lipid Raft Disruptors, a Novel Carboxamido-Steroid and Methyl β-Cyclodextrin, in Mice by Inhibiting Transient Receptor Potential Vanilloid 1 and Ankyrin 1 Channel Activation
por: Horváth, Ádám, et al.
Publicado: (2020) -
Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation
por: Horváth, Ádám, et al.
Publicado: (2021) -
Prerequisite Binding Modes Determine the Dynamics of Action of Covalent Agonists of Ion Channel TRPA1
por: Zsidó, Balázs Zoltán, et al.
Publicado: (2021)